Skip to main content

Valkova Silvia

Description

The 2012 National Strategy for Biosurveillance (BSV) recognizes that a well-integrated national BSV enterprise must provide essential information for better decision making at all levels. Submitting an electronic bill following HC services is the most mature and widely used form of eHealth. HIPAA-compliant eHRCs captured in e-commerce can be consolidated into big HC data centers and used for many purposes including BSV. eHRCs are standardized and each claim contains pertinent person, place, and time information that can be leveraged for BSV. IMS Health (IMS) is a global HC information company and maintains one of worldÕs largest eHealth data centers that processed information including eHRCs on >260M unique U.S. patients in 2012.

Objective

This paper describes how high-volume electronic healthcare (HC) reimbursement claims (eHRCs) from providers' offices and retail pharmacies can be used to provide timely and accurate influenza-like illness (ILI) situational awareness at state and CBSA levels

Submitted by elamb on
Description

Chikungunya virus disease (CHIK) is a mosquito-borne viral infection currently widespread in the Caribbean with the potential for emergence and endemicity in the U.S. via infected travelers and local mosquito vectors. CHIK disease can be severe and disabling with symptoms similar to dengue. CHIK is not a U.S. nationally notifiable disease and tracking travel-associated and locally acquired cases is currently dependent on voluntary reporting via ArboNET. While ArboNET cases are laboratory confirmed and highly specific, ArboNET is a passive surveillance system where representativeness and timeliness may be lacking. In contrast, submitting an electronic bill following HC services is the most mature and widely used form of eHealth. Providers are highly motivated to submit claims for reimbursement and the eHRC process is ubiquitous in the U.S. HC system. HIPAA-compliant eHRCs from provider offices can be captured in e-commerce and consolidated into electronic data warehouses and used for many purposes including public health surveillance. eHRCs are standardized and each claim contains pertinent person, place, and time information as well as ICD-9 diagnostic codes. IMS Health (IMS) is a global HC information company and maintains one of world’s largest eHealth data warehouses that processes ~1 billion provider office eHRCs annually. IMS consolidates eHRCs from >60% of all U.S. office-based providers from all parts of the U.S. The size and predictability of the eHRC flow into the IMS data warehouse supports projections of national estimates and time trends of conditions of interest.

Objective

This paper describes how high-volume electronic healthcare (HC) reimbursement claims (eHRCs) from providers’ offices can be used to supplement Chikungunya surveillance in the U.S.

 

 

Submitted by uysz on
Description

Missed opportunities for influenza vaccination in office-based settings occur when patients (who are inclined to accept influenza vaccination if a provider recommends it) remain unvaccinated after a fall/winter healthcare visit. Healthcare providers can be very influential in encouraging patients to obtain influenza vaccination, but little is known in real-time during annual campaigns of how many and what type of providers are actually giving vaccinations in office settings. Many factors affect the ultimate population coverage including taking advantage of opportunities to vaccinate during medical visits. This suggests that provider vaccination behavior, if leveraged, could result in higher rates of influenza vaccine coverage. “Big” healthcare data in the form of high volume streams of electronic healthcare reimbursement claims (eHRCs) can potentially be used to track influenza vaccine administration practices in office-based settings in near real-time, thus empowering public health officials to provide this feedback to practitioners and potentially modify behaviors.

Objective

This paper describes the results of formative research to develop a new metric for public health officials to use in near-real-time tracking of the weekly participation of office-based providers in community influenza vaccination campaigns.

Submitted by teresa.hamby@d… on
Description

Zika virus disease and Zika virus congenital infection are nationally notifiable conditions that became prominent recently as a growing number of travel-associated infections have been identified in the United States. The Centers for Disease Control and Prevention (CDC) have dedicated significant time and effort on determining and addressing the risks and impact of Zika on pregnant women and their babies who are most vulnerable to the disease. CDC relies on two sources of information, reported voluntarily by healthcare providers, to monitor Zika virus disease: ArboNET and the newly established U.S. Zika Pregnancy Registry. A study by IMS Health compared U.S.trends of the Zika virus disease in general and pregnant women with Zika virus disease in particular observed in an IMS healthcare claims database and the CDC ArboNET and the newly established U.S. ZikaPregnancy Registry.

Objective

Demonstrate the value of consolidated claims data from community healthcare providers in Zika Virus Disease surveillance at local level.

Submitted by teresa.hamby@d… on